Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease

doi:10.4331/wjbc.v6.i3.162

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15573)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

1113

WORD

380

HTML

10502

Figures (1-3)

241

Tables (1-6)

284

Sum=12520

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1319

Download

1734

Sum=3053

Aug 26, 2015 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (126)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Biol Chem. Aug 26, 2015; 6(3): 162-208
Published online Aug 26, 2015. doi: 10.4331/wjbc.v6.i3.162

Table 3 The deregulated expression of the canonical myomiRs in different cancers

MiR-1	MiR-206	MiR-133a	MiR-133b	Cancer type	Ref.
		+	+	Progressive bladder cancer (TCC)	[122]
-		-		Bladder cancer (TCC)	[93,156]
-		-	-	Bladder cancer (TCC)	[92,144]
-	-	-	-	Bladder cancer	[127]¹
-	-	-	-	Bladder cancer	[128]¹
-		-	-	Muscle-invasive bladder cancer	[92]
	-			Proliferating breast cancer	[108]
	-			ERα-positive breast cancer	[109]
-			-	Breast cancer	[95]
			+	Progressive cervical carcinoma	[117,121]
-	-			Chordoma	[90]
	+			Colon cancer	[116]
-				Colon cancer	[101]
		-		CRC	[104,136]
			-	CRC	[86,87]
			+/-	Liver metastasis compared to primary CRC	[118]
-			-	Colon cancer	[95]
		-	-	Progressive GIST	[281]
		-		HNSCC	[143]
			-	HNSCC	[114]
	-			EEC	[110]
		-		ESCC	[132]
-		-	-	ESCC	[94]
	-			Laryngeal SCC cells	[113]
-		-		MSSCC	[137]
		-		TSCC	[111,112]
-				HCC	[98]
+			+	Liver cancer	[95]
-				Lung cancers: (NSCLC, adenocarcinomas, lung SCC, large cell carcinoma, and bronchoalveolar cell carcinoma)	[100]
	-			High metastasis lung tumors	[107]
		-		Lung SCC tissue; lung-SCC cell lines	[115]
			-	NSCLC	[85,105]
-	-			Lung adenocarcinomas; NSCLC cells	[99]
		-	-	Lung carcinomas	[85,115,131]
-			-	Lung cancer	[95]
-			-	Lymphoma	[95]
		+		AML	[120,151]
		+		Multiple myeloma	[152]
			+	Progressive prostate cancer	[123]
-	(-)	-		Prostate cancer	[102]
-			-	Prostate cancer	[95]
-			-	Recurrent prostate cancer compared to non-recurrent cancer	[96]
		-	-	Hormone-insensitive prostate cancer cells	[102]
-		-	-	Osteosarcoma	[91]
-			-	Ovarian cancer	[95]
		-		PDAC	[103]
		-		RCC	[138]
-	-			Rhabdomyosarcoma	[88,89]
-			-	Testicular cancer	[95]

¹DS: Deep sequencing; TCC: Transitional cell carcinoma; CRC: Colorectal cancer; GIST: Gastrointestinal stromal tumor; HNSCC: Head and neck squamous cell carcinoma; EEC: ERα-positive endometrioid adenocarcinoma; ESCC: Esophageal squamous cell carcinoma; MSSCC: Maxillary sinus squamous cell carcinoma; TSCC: Tongue squamous cell carcinoma; HCC: Hepatocellular carcinoma; NSCLC: Non-small-cell lung cancer; AML: Acute myeloid leukaemia; PDAC: Pancreatic ductal adenocarcinoma; RCC: Renal cell carcinoma.

Citation: Mitchelson KR, Qin WY. Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease. World J Biol Chem 2015; 6(3): 162-208
URL: https://www.wjgnet.com/1949-8454/full/v6/i3/162.htm
DOI: https://dx.doi.org/10.4331/wjbc.v6.i3.162